SCHAAN, Lichtenstein--Ivoclar Vivadent has announced a materials partnership with Nobel Biocare.
This partnership allows dentists and laboratory technicians to benefit from the esthetic, restorative and prosthetic systems strengths of both companies.
Ivoclar Vivadent and Nobel Biocare have signed a global agreement to provide and commercialize high-performance ceramic and acrylic materials, allowing Nobel Biocare to expand its NobelProcera restorative and prosthetic portfolio through new products, solutions, and materials.
"We see a partnership with Nobel Biocare as an ideal combination of premium skills and focused commitment to quality esthetic restorative and prosthetic dentistry," said Robert Ganley, CEO Ivoclar Vivadent AG.
"Ivoclar Vivadent is very pleased to have IPS e.max as a material solution within the NobelProcera system."
Ivoclar Vivadent will provide Nobel Biocare with newly developed acrylic material for temporary crowns and bridges. The acrylic material from Ivoclar Vivadent, together with the NobelProcera CAD design and CAM manufacturing process, will represent a durable prosthetic solution with surface finish and fit.
The new temporary solution is scheduled to be introduced to the market in March/April of 2010.
Furthermore, Ivoclar Vivadent will supply Nobel Biocare with IPS e.max CAD lithium disilicate ceramics for the milling of full-contour crowns. IPS e.max lithium disilicate ceramic material offers material strength, translucency for esthetics and long-term durability.
IPS e.max ceramics can be used for final restorations on natural teeth and implants. Nobel Biocare plans to start the launch of its new range of IPS e.max products in mid-2010.
Ivoclar Vivadent offers a broad choice of ceramic veneering solutions. Both parties have joined forces to develop a certification process that helps ensure a high standard of final restorations based on their combined product offerings. NobelProcera customers will benefit from ceramic and composite veneering solutions and procedures fully compatible with NobelProcera products and materials.
According to the agreement, the prosthetic collaboration includes the development of new materials, training and education and commercial activities. Nobel Biocare will recommend the usage of veneering material in combination with NobelProcera products.
In addition, NobelProcera customers will receive access to Ivoclar Vivadent's denture teeth portfolio through the new NobelProcera CAD software.
Both parties will combine their training and education competencies and offer customized training programs for temporary solutions, IPS e.max solutions, veneering, denture prosthetics and treatment planning, preparation and placement techniques. Furthermore, Ivoclar Vivadent and Nobel Biocare will cooperate in clinical research and clinical studies.
"Ivoclar Vivadent is committed to developing innovative dental material technologies for advanced fabrication technologies such as CAD/CAM," said Ganley.
"Simply stated, our goal is to develop new technologies for new technologies. As a market leader in material systems, we have and will continue to partner with the market-leading digital-based CAD/CAM systems. We believe that our clear focus on materials gives us both a clear developmental advantage and our partners an equally clear partnership opportunity."
Nobel Biocare will establish a preferred partner program targeting a select number of major global dental material providers.
"This partnership with the world-leading dental materials provider, Ivoclar Vivadent, marks another step in our strategy to strengthen NobelProcera's position as a key offer in CAD/CAM dentistry," said Domenico Scala, CEO Nobel Biocare.
"This cooperation, which also encompasses research, development and education, ensures optimal product fit between the two providers, leading to better clinical results for dental professionals and their patients."
For more information, go to Ivoclar Vivadent.
To read more about Ivoclar Vivadent, go to Ivoclar Vivadent.
To comment on this topic, go to PennWell Dental Community site.